CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 55 filers reported holding CATALYST BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is 2.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $367,000 | -10.7% | 89,400 | -5.7% | 0.00% | 0.0% |
Q2 2021 | $411,000 | -4.6% | 94,800 | +11.0% | 0.00% | -20.0% |
Q1 2021 | $431,000 | +643.1% | 85,400 | +532.6% | 0.01% | +400.0% |
Q3 2020 | $58,000 | -94.3% | 13,500 | -92.3% | 0.00% | -92.9% |
Q2 2020 | $1,022,000 | +73.5% | 174,286 | +245.1% | 0.01% | -56.2% |
Q2 2018 | $589,000 | -15.0% | 50,500 | +87.9% | 0.03% | -38.5% |
Q1 2018 | $693,000 | – | 26,871 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
DRW Securities, LLC | 12,000 | $164,000 | 0.02% |